The inaugural meeting of the CliniSys Innovation Board was held on the 22nd October at the Belfry, Birmingham. Fiona Pearson, CliniSys CEO opened proceedings by confirming the objective for the creation of the CliniSys Innovation Board was to primarily understand and discuss the future direction of pathology and how IT can help support and influence innovation and ask “what will Laboratory Medicine look like in 2025?”.
CliniSys has been delivering IT solutions to enable pathology networks for over 25 years and has become a trusted advisor to our customers. The objective for the creation of the CliniSys Innovation Board is primarily to understand and discuss the future direction of pathology and how IT can help support and influence innovation. This board will enable all participants to identify the latest evolving pathology requirements so that innovative solutions, which help deliver improvements in quality and efficiency, can be developed that are aligned and supportive of the transformational priorities in pathology.
The Innovation Board was composed of influential clinicians and thought leaders who have the passion and vision to influence the future of pathology and embrace the supporting and innovative role that IT can offer.
With the UK pathology landscape being reconfigured on a scale never seen before, this event provides an excellent opportunity to have an early influence on new directives.
This was an extremely interactive event and each group member was first asked to identify and discuss their top five changes they believe will affect pathology in the next 10 years providing a high level summary of the anticipated requirement and why it is needed. Any barriers to change (IT or otherwise) were discussed along with the right drivers to make this change happen. Anticipated timeframes were also debated and how the changes could to be funded. Although most had far more than five examples of possible changes to highlight, there were a few common themes and trends which were discussed in greater depth.